{
  "meta": {
    "title": "20_Anti-Epileptics_Ii",
    "url": "https://brainandscalpel.vercel.app/20-anti-epileptics-ii-c0ba58ab.html",
    "scrapedAt": "2025-11-30T12:34:10.675Z"
  },
  "questions": [
    {
      "text": "Which of the following anti-epileptics is an AMPA glutamate receptor antagonist?",
      "choices": [
        {
          "id": 1,
          "text": "Levetiracetam"
        },
        {
          "id": 2,
          "text": "Brivaracetam"
        },
        {
          "id": 3,
          "text": "Perampanel"
        },
        {
          "id": 4,
          "text": "Rufinamide"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Perampanel </strong>is a selective non-competitive<strong> antagonist of the AMPA-type glutamate receptor.</strong> It is approved for adjunctive therapy of <strong>focal-onset</strong> seizures.</p>\n<p>Options A and B: Levetiracetam and brivaracetam act on SV2A proteins and modulates GABA and glutamate release.</p>\n<p>Option D: Rufinamide acts on voltage-gated sodium channels.</p><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1578",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following mechanisms of action is observed with levetiracetam?",
      "choices": [
        {
          "id": 1,
          "text": "GABA transaminase inhibition"
        },
        {
          "id": 2,
          "text": "GABA transporter inhibition"
        },
        {
          "id": 3,
          "text": "Binding to synaptic vesicular protein SV2A"
        },
        {
          "id": 4,
          "text": "Inhibition of neuronal sodium channel"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Levetiracetam </strong>has a binding affinity to synaptic vesicular<strong> protein SV2A.&nbsp;</strong>SV2A plays a role in vesicle recycling following exocytosis of neurotransmitter</p>\n<p>When levetiracetam bind to this synaptic vesicular protein, it decreases the <strong>release</strong> of excitatory neurotransmitter <strong>glutamate</strong> thus <strong>preventing seizures.</strong>&nbsp;</p>\n<p>Levetiracetam also&nbsp;<strong>inhibits N-type Ca2+ channels</strong> and Ca2+ release from intracellular stores.Thus, it is considered a <strong>broad-spectrum</strong> antiepileptic as it has an effect on multiple channels.</p><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2264",
      "difficulty": "easy"
    },
    {
      "text": "A known epileptic patient on levetiracetam has been seizure-free for 2 years. But he develops agitation and anger issues interfering with his day-to-day activities as a result of the drug intake. Which of the following measures is to be taken next?",
      "choices": [
        {
          "id": 1,
          "text": "Slowly taper the drug over next 6 months"
        },
        {
          "id": 2,
          "text": "Continue levetriacetam since a 5 year seizure free interval is needed"
        },
        {
          "id": 3,
          "text": "Stop levetiracetam and start on a different anti-epileptic"
        },
        {
          "id": 4,
          "text": "Discontinue the drug as he is seizure free"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The mood changes observed in the above patient must be due to an adverse effect of levetiracetam. <strong>Abrupt stoppage</strong> of the drug can result in <strong>rebound</strong> seizures. So the best management will be to <strong>slowly taper the drug</strong> over the <strong>next 6 months</strong>.</p>\n<p>Adverse effects of <strong>levetiracetam</strong>:</p>\n<ul>\n<li>Somnolence</li>\n<li>Asthenia</li>\n<li>Ataxia</li>\n<li>Dizziness.</li>\n<li><strong>Mood and behavioral changes</strong></li>\n<li>Psychotic reactions (rare)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9512",
      "difficulty": "medium"
    },
    {
      "text": "Tiagabine has been initiated as an adjunctive treatment for focal seizures in a patient. What is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibiting GABA transaminase"
        },
        {
          "id": 2,
          "text": "Increasing GABA synthesis"
        },
        {
          "id": 3,
          "text": "Inhibiting GABA transporter"
        },
        {
          "id": 4,
          "text": "Inhibiting glutamate release"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Tiagabine</strong>&nbsp;acts by inhibiting<strong>&nbsp;</strong>the<strong> GAT1 GABA transporter,</strong>&nbsp;thereby <strong>reducing</strong> its <strong>reuptake</strong> into neurons<strong>.</strong> It also increases the duration of inhibitory impulses in the synapse by prolonging the action of GABA.</p>\n<p>Tiagabine is approved as an <strong>add-on</strong> therapy for <strong>refractory partial seizures</strong> with or without generalization.</p>\n<p>Other antiepileptic drugs that have <strong>GABA enhancing activity</strong> are <strong>vigabatrin</strong> and <strong>stiripentol</strong>.</p><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2272",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old patient diagnosed with Lennox-Gastaut syndrome was prescribed a drug with NMDA antagonist activity. Identify the drug.",
      "choices": [
        {
          "id": 1,
          "text": "Memantine"
        },
        {
          "id": 2,
          "text": "Riluzole"
        },
        {
          "id": 3,
          "text": "Ketamine"
        },
        {
          "id": 4,
          "text": "Felbamate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Felbamate</strong> is the<strong> NMDA receptor antagonist </strong>prescribed to this patient. It also potentiates GABA action. It is indicated in refractory primary or secondary generalized seizures and <strong>Lennox-Gastaut syndrome.</strong></p>\n<p>Felbamate is associated with aplastic anemia and liver failure.</p>\n<p>Option A: Memantine is used in Alzheimer’s disease.</p>\n<p>Option B: Riluzole is used in amyotrophic lateral sclerosis.</p>\n<p>Option C<strong>:</strong> Ketamine causes dissociative anesthesia and used in general anesthesia.</p><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2269",
      "difficulty": "medium"
    },
    {
      "text": "An antiepileptic agent which acts by opening neuronal potassium channels was prescribed to a patient admitted to the neurology ward. On discharge, the patient was asked to have a regular ophthalmological examination every 6 months. Which drug is most likely prescribed?",
      "choices": [
        {
          "id": 1,
          "text": "Ezogabine"
        },
        {
          "id": 2,
          "text": "Rufinamide"
        },
        {
          "id": 3,
          "text": "Vigabatrin"
        },
        {
          "id": 4,
          "text": "Gabaculine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Ezogabine</strong> (retigabine) acts by <strong>opening</strong> <strong>neuronal</strong> <strong>potassium channels</strong>. By opening the K<sup>+</sup> channels, stabilizes the resting membrane potential and reduces the excitability of the nerve membrane.</p>\n<p>FDA recommends that patients on chronic ezogabine therapy need <strong>visual acuity</strong> and <strong>fundus</strong>&nbsp;<strong>examination</strong>&nbsp;every 6 months due to the possibility&nbsp;of <strong>retinal abnormalities.</strong>&nbsp; &nbsp;</p>\n<p>Option B:<strong>&nbsp;</strong>Rufinamide acts by prolonging an inactive state of the Na<sup>+</sup> channel.</p>\n<p>Option C:&nbsp; Vigabatrin is a GABA transaminase inhibitor.</p>\n<p>Option D: Gabaculine is an irreversible GABA reuptake inhibitor, that has only experimental value, due to high toxicity.&nbsp;</p><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2278",
      "difficulty": "medium"
    },
    {
      "text": "All of the following statements are true about zonisamide except:",
      "choices": [
        {
          "id": 1,
          "text": "Indicated in focal seizures"
        },
        {
          "id": 2,
          "text": "Nephrolithiasis is not a side effect"
        },
        {
          "id": 3,
          "text": "Inhibits T type calcium channel"
        },
        {
          "id": 4,
          "text": "Blocks low voltage gated Na+ channel"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Nephrolithiasis</strong>&nbsp;is a side effect of <strong>zonisamide</strong>.</p>\n<p>Zonisamide is a broad-spectrum antiepileptic, that acts by blocking low voltage Na+ channels and T type calcium channels.&nbsp;It also has <strong>carbonic anhydrase inhibiting activity</strong> that may result in metabolic acidosis and the formation of renal stones.</p>\n<p>It is used in the treatment of <strong>focal seizures.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2265",
      "difficulty": "medium"
    },
    {
      "text": "Patients on which of the following antiepileptic drugs will experience weight loss?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium valproate"
        },
        {
          "id": 2,
          "text": "Vigabatrin"
        },
        {
          "id": 3,
          "text": "Topiramate"
        },
        {
          "id": 4,
          "text": "Carbamazepine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Topiramate</strong> causes <strong>weight loss</strong> as one of its common side effects.&nbsp;</p>\n<p>Topiramate has mixed mechanisms of action<strong>:</strong></p>\n<ul>\n<li>Reduces voltage gate Na+ currents</li>\n<li>Activates hyperpolarizing K+ currents</li>\n<li>Enhances postsynaptic GABAA current</li>\n<li>Limits the activation of AMPA subtype of glutamate receptors.</li>\n</ul>\n<p>Topiramate is used in <strong>focal seizures, GTCS </strong>and<strong>&nbsp;Lennox-Gastaut syndrome</strong>.</p>\n<p>The side effects:&nbsp;</p>\n<ul>\n<li>Cognitive impairment</li>\n<li><strong>Weight loss</strong></li>\n<li>Fatigue</li>\n<li>Renal calculi</li>\n</ul>\n<p>Sodium valproate, vigabatrin (highest incidence), and carbamazepine cause <strong>weight gain.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2268",
      "difficulty": "easy"
    },
    {
      "text": "A 55-year-old patient presented to the OPD with complaints of pain over a healed dermatomal rash on his lateral chest wall. Gabapentin was prescribed to this patient. The analgesic activity of this drug is mainly exerted by which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Increasing the duration of GABA Cl- channel opening"
        },
        {
          "id": 2,
          "text": "Inhibiting the GABA transaminase enzyme"
        },
        {
          "id": 3,
          "text": "Inhibiting the uptake of GABA at the presynaptic membrane"
        },
        {
          "id": 4,
          "text": "Inhibiting the Ca2+ channel current"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Gabapentin</strong> exerts its analgesic activity by <strong>inhibiting</strong> the<strong> Ca2+ channel current</strong> in this patient who is most likely suffering from <strong>post-herpetic neuralgia.</strong></p>\n<p class=\"p1\">Gabapentin and pregabalin have close structural similarity to GABA. Still, they <strong>do not act through the effects of GABA receptors</strong> or&nbsp;any other mechanism related to GABA-mediated neurotransmission.&nbsp;</p>\n<p class=\"p1\">They inhibit the calcium channel current which decreases the entry of calcium in the presynaptic neuron. When calcium entry in the neuron is reduced, there is a decrease in the release of glutamate. This lowers the excitability of the neuron, thus reducing seizure activity.</p>\n<p class=\"p1\">Therapeutic use of these drugs:&nbsp; &nbsp; &nbsp;</p>\n<p class=\"p1\"><strong>Gabapentin</strong>: Focal seizures, postherpetic neuralgia pain</p>\n<p class=\"p1\"><strong>Pregabalin</strong>: Focal seizures,&nbsp;postherpetic neuralgia pain,&nbsp;diabetic neuropathy pain, spinal cord injury pain, fibromyalgia pain.</p>\n<p class=\"p1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2261",
      "difficulty": "hard"
    },
    {
      "text": "An infant presents with sudden jerky movements of the head, neck and arms. On EEG evaluation, a characteristic pattern of hypsarrhythmia is observed. Which is the GABA transaminase inhibitor approved for the treatment of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Vigabatrin"
        },
        {
          "id": 2,
          "text": "Tiagabine"
        },
        {
          "id": 3,
          "text": "Progabide"
        },
        {
          "id": 4,
          "text": "Pregabalin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario along with<strong> hypsarrytmia </strong>on EEG is suggestive of <strong>West syndrome.&nbsp;</strong><strong>Vigabatrin</strong> is an <strong>inhibitor </strong>of the<strong> GABA transaminase </strong>that can be used in this condition.&nbsp;</p>\n<p>Inhibition of the enzyme GABA transaminase leads to an increase in the concentration of GABA in the synaptic cleft which is an&nbsp;inhibitory neurotransmitter. This contributes to its anticonvulsant property of vigabatrin.&nbsp;</p>\n<p>West syndrome is a rare type of<strong> epilepsy syndrome</strong> that begins in <strong>infancy</strong>. It is characterized by a triad of:</p>\n<ul>\n<li aria-level=\"1\">Infantile seizures (also called salaam spells)</li>\n<li aria-level=\"1\">Developmental regression</li>\n<li aria-level=\"1\">Hypsarrhythmia i.e Himalayan wave pattern on EEG</li>\n</ul>\n<p>Treatment of West syndrome includes:</p>\n<ul>\n<li>ACTH</li>\n<li>Vigabatrin if associated with<strong> tuberous sclerosis</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2252",
      "difficulty": "easy"
    },
    {
      "text": "What is the drug of choice in the treatment of infantile spasms?",
      "choices": [
        {
          "id": 1,
          "text": "ACTH"
        },
        {
          "id": 2,
          "text": "Phenobarbitone"
        },
        {
          "id": 3,
          "text": "Carbemazepine"
        },
        {
          "id": 4,
          "text": "Vigabatrin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>drug of choice</strong> in the treatment of <strong>infantile spasms</strong> or West syndrome is <strong>adrenocorticotropic hormone</strong> (ACTH.)</p>\n<p>The mechanism of action of ACTH or glucocorticoids is unknown but may involve a reduction in inflammatory processes. <strong>Vigabatrin</strong> is used if the spasms are associated with <strong>tuberous sclerosis</strong>.&nbsp;</p>\n<p>Other antiseizure medications that may be helpful are valproate, topiramate, zonisamide, or benzodiazepines.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2279",
      "difficulty": "easy"
    },
    {
      "text": "Which antiepileptic drug is associated with permanent visual loss?",
      "choices": [
        {
          "id": 1,
          "text": "Topiramate"
        },
        {
          "id": 2,
          "text": "Ethosuximide"
        },
        {
          "id": 3,
          "text": "Vigabatrin"
        },
        {
          "id": 4,
          "text": "Felbamate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Vigabatrin</strong> is associated with <strong>progressive</strong> and <strong>permanent visual loss.</strong></p>\n<p>It is a <strong>GABA transaminase inhibitor</strong> indicated in:</p>\n<ul>\n<li>West syndrome associated with tuberous sclerosis</li>\n<li>Refractory focal seizures with impaired awareness.&nbsp; &nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2253",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following antiepileptic drugs are approved for prophylaxis in patients suffering from migraines?<div class='question-desc-html'><ol>\n<li>Sodium valproate</li>\n<li>Carbamazepine</li>\n<li>Topiramate</li>\n<li>Rufinamide</li>\n<li>Phenytoin</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3 and 4"
        },
        {
          "id": 2,
          "text": "3 and 5"
        },
        {
          "id": 3,
          "text": "1, 4 and 5"
        },
        {
          "id": 4,
          "text": "1 and 3"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sodium valproate,</strong>&nbsp;<strong>topiramate </strong>and gabapentin&nbsp;are approved anti-epileptics for use in <strong>prophylaxis of migraine</strong>.</p>\n<p>Carbamazepine, phenytoin and rufinamide are not used for prophylaxis of a migraine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2273",
      "difficulty": "medium"
    },
    {
      "text": "A 22-year-old female is brought to the casualty with seizures for the past 10 minutes. History from relatives suggests no seizure-free intervals in the past 10 minutes. After stabilizing the vitals of the patient, which is the first drug you administer to the patient?",
      "choices": [
        {
          "id": 1,
          "text": "Lorazepam"
        },
        {
          "id": 2,
          "text": "Diazepam"
        },
        {
          "id": 3,
          "text": "Phenobarbitone"
        },
        {
          "id": 4,
          "text": "Thiopentone sodium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This scenario described above is of&nbsp;<strong>status epilepticus</strong>. The first drug used in the management is <strong>lorazepam.</strong></p>\n<p>Status epilepticus refers to <strong>continuous</strong> seizures or <strong>repetitive</strong>, <strong>discrete</strong> seizures with <strong>impaired consciousness</strong> in the inter-ictal period. For practical purposes, it is defined as any one of the following:</p>\n<ul>\n<li aria-level=\"1\">Continuing seizures &gt;5 minutes or</li>\n<li aria-level=\"1\">No regaining of consciousness between 2 seizures.</li>\n</ul>\n<p>Management of status epilepticus:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0c41b7774f474be49e4a076917ec371cx1096x1496.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2255",
      "difficulty": "easy"
    },
    {
      "text": "A 25-year-old newly married female comes to the OPD with a positive urine pregnancy test. Her history is suggestive of antiepileptic use since 8 years. Which of the following statements is incorrect about further management in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Anti epileptic agents has to be continued at stabilised doses"
        },
        {
          "id": 2,
          "text": "Immediately stop antiepileptics once pregnancy is detected"
        },
        {
          "id": 3,
          "text": "Folate supplementation is a must"
        },
        {
          "id": 4,
          "text": "No antiepiletic is deemed safe in pregnancy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Stopping antiepileptics abruptly</strong> once pregnancy is detected in this patient is <strong>not recommended</strong>. If this is done, then there is a lot of <strong>risk</strong> to the <strong>fetus</strong> by uncontrolled seizures and can result in <strong>anoxia</strong> and <strong>intellectual disability.</strong> Antiepileptics have to be continued and then the <strong>dose</strong> can be<strong> tapered slowly</strong> if there are no episodes of seizures.</p>\n<p>Management of seizures in pregnancy:&nbsp;</p>\n<ul>\n<li>If the patient is a known case of seizure and is on any antiepileptic drug: The same prescribed drug is continued</li>\n<li>If the first episode occurs during pregnancy: The drug preferred is either <strong>lamotrigine</strong> or <strong>levetiracetam</strong></li>\n<li><strong>Folic acid</strong> (1-4 mg/day) should be given to all</li>\n</ul>\n<p>No antiepileptic is deemed safe in pregnancy. So, it is important to have the patient on <strong>monotherapy</strong> at the <strong>lowest effective dose</strong>, especially during the <strong>first trimester.</strong>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2283",
      "difficulty": "easy"
    },
    {
      "text": "An infant is born with a birth defect as shown in the image below. It is the most common teratogenic effect of:",
      "choices": [
        {
          "id": 1,
          "text": "Phenytoin"
        },
        {
          "id": 2,
          "text": "Topiramate"
        },
        {
          "id": 3,
          "text": "Sodium valproate"
        },
        {
          "id": 4,
          "text": "Phenobarbital"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above illustration is suggestive of an infant with<strong> spina bifida</strong> of the open type which is the <strong>most common teratogenic</strong> effect of <strong>sodium valproate.</strong>&nbsp;</p>\n<p>Option A: Phenytoin is usually associated with fetal hydantoin syndrome.&nbsp;</p>\n<p>Option B: Topiramate has shown growth defects in animal studies and hypospadias have been shown in the male fetus but the definite relationship is lacking.</p>\n<p>Option D: Phenobarbital has teratogenic effects similar to phenytoin.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ba16aff3a87f412ab13b9cea93dcd207.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2286",
      "difficulty": "medium"
    },
    {
      "text": "Which is the treatment of choice for juvenile myoclonic epilepsy in pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "Levetiracetam"
        },
        {
          "id": 2,
          "text": "Carbamazepine"
        },
        {
          "id": 3,
          "text": "Vigabatrin"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The drug of choice for <strong>juvenile myoclonic epilepsy</strong>&nbsp;(JME) in pregnancy is <strong>levetiracetam</strong>. <strong>Lamotrigine</strong>&nbsp;or levetiracetam are <strong>alternative</strong> first-line in pregnancy as they have fewer teratogenic effects.</p>\n<p>The drug of choice for JME is <strong>valproate</strong>.&nbsp;However, in pregnant women or women of childbearing age, valproate should be avoided because of the increased risks of fetal malformations and neurodevelopmental delay.</p>\n<p>Carbamazepine, vigabatrin, and phenytoin are <strong>not indicated</strong> in juvenile myoclonic epilepsy as they may <strong>worsen myoclonic jerks</strong> and<strong> absence</strong> <strong>seizures.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2290",
      "difficulty": "easy"
    },
    {
      "text": "A 29-year-old primigravida, at 4-months period of gestation and history of juvenile myoclonic epilepsy, visits your clinic. She has been regularly taking sodium valproate and is now concerned about the medication possibly affecting her child. What would you suggest to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Immediately taper valproate and start lamotrigine"
        },
        {
          "id": 2,
          "text": "Continue valproate with serial drug monitoring"
        },
        {
          "id": 3,
          "text": "Switch to carbamazepine"
        },
        {
          "id": 4,
          "text": "Add lamotrigine to valproate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given scenario, the patient should be advised to <strong>continue valproate</strong>, and <strong>serial drug monitoring</strong> should be done.&nbsp;</p>\n<p>Valproate has a higher teratogenic potential. It is usually avoided before conception if other antiepileptics with less teratogenicity (lamotrigine. levetiracetam) can be used. But for a woman who is <strong>pregnant</strong> and is already taking valproate, <strong>changing the drug</strong> is <strong>not recommended</strong>.</p>\n<p>Option A - The patient is presenting in the <strong>second trimester</strong> when organogenesis would have been complete. Therefore, tapering the drug and introducing lamotrigine is not an option as precipitating seizures has a greater risk of fetal harm at this stage.</p>\n<p>Option C: Carbamazepine is not indicated in JME as it may worsen the myoclonic jerks and absence seizures.&nbsp;</p>\n<p>Option D- Adding additional drugs to stabilized doses may increase teratogenicity. So adding lamotrigine to valproate is also not a viable option.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2284",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is recommended for prophylaxis in a pregnant woman who is on anti-epileptic drugs with an enzyme-inducing property?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin K"
        },
        {
          "id": 2,
          "text": "Anti D immunoglobulin"
        },
        {
          "id": 3,
          "text": "Indomethacin"
        },
        {
          "id": 4,
          "text": "Prostacyclin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Vitamin K</strong>&nbsp;is recommended for <strong>prophylaxis</strong> in pregnant women who are on <strong>antiepileptic drugs</strong> having <strong>enzyme-inducing properties.</strong></p>\n<p>Antiepileptic drugs with enzyme inducing properties:</p>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Topiramate</li>\n<li>Phenobarbital</li>\n<li>Primidone</li>\n</ul>\n<p>They <strong>induce CYP enzymes</strong> that interfere with the <strong>metabolism</strong> of <strong>vitamin K</strong>. Deficiency of vitamin K-dependent clotting factors can occur in the newborn leading to <strong>coagulopathy</strong> and intracerebral <strong>hemorrhage</strong>.</p>\n<p>Although hemorrhage is uncommon, the <strong>mother</strong> should be treated with <strong>oral vitamin K, </strong>20 mg/day in the last two weeks of pregnancy. The <strong>infant</strong> should receive an <strong>intramuscular injection of vitamin K</strong> (1 mg) at birth.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2288",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following antiepileptics is effective in Lennox-Gastaut syndrome, but shows the highest propensity to cause rashes in young children warranting its withdrawal?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium valproate"
        },
        {
          "id": 2,
          "text": "Levetiracetam"
        },
        {
          "id": 3,
          "text": "Lamotrigine"
        },
        {
          "id": 4,
          "text": "Vigabatrin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lamotrigine</strong> is effective in <strong>Lennox-Gastaut syndrome</strong> and has the highest propensity to cause <strong>rashes in young children</strong>.</p>\n<p>Lamotrigine is also associated with toxic epidermal necrosis and <strong>Stevens-Johnson Syndrome</strong> in some patients. The incidence of serious rash and other serious skin conditions is higher with lamotrigine than other anti-epileptics provided in the options. The occurrence of <strong>rash warrants</strong>&nbsp;the<strong> stoppage</strong> of the drug.&nbsp;</p>\n<p>Option A: Sodium valproate is the drug of choice in Lennox-Gastaut syndrome. It can cause fulminant hepatitis especially in children &lt; 2 years.</p>\n<p>Option B: Levetiracetam is also effective in most of the seizures present in Lennox-Gastaut syndrome. It can increase blood pressure in children &lt; 4 years.</p>\n<p>Option D: Vigabatrin is also effective in Lennox-Gastaut syndrome, especially as an&nbsp;add-on therapy. It can cause permanent visual field defects.</p><hr><h3>Related Pearl: Important Adverse Effects of Anti-epileptic Drugs</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Antiepileptic drugs</strong></p>\n</td>\n<td>\n<p><strong>Adverse effects</strong></p>\n</td>\n</tr>\n<tr>\n<td>Carbamazepine</td>\n<td>Stevens-Johnson syndrome (SJS), diplopia, ataxia, hyponatremia</td>\n</tr>\n<tr>\n<td>Phenytoin</td>\n<td>Gum hyperplasia, hirsutism, osteomalacia, ataxia</td>\n</tr>\n<tr>\n<td>Valproic acid</td>\n<td>Hepatotoxicity, thrombocytopenia, transient alopecia, tremors, pancreatitis</td>\n</tr>\n<tr>\n<td>Phenobarbital</td>\n<td>Sedation, depression, ataxia, automatism</td>\n</tr>\n<tr>\n<td>Vigabatrin</td>\n<td>Loss of peripheral vision</td>\n</tr>\n<tr>\n<td>Felbamate</td>\n<td>Fulminant hepatic failure, aplastic anemia</td>\n</tr>\n<tr>\n<td>Lamotrigine</td>\n<td>Hypersensitivity reactions, SJS</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Paresthesias, renal calculi, weight loss, acute glaucoma</td>\n</tr>\n<tr>\n<td>Oxcarbazepine</td>\n<td>Hyponatremia, SJS</td>\n</tr>\n<tr>\n<td>Ezogabine</td>\n<td>Urinary retention</td>\n</tr>\n<tr>\n<td>Zonisamide</td>\n<td>Renal calculi</td>\n</tr>\n<tr>\n<td>Perampanel</td>\n<td>Homicidal ideation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2275",
      "difficulty": "hard"
    },
    {
      "text": "Patients receiving which of the following anti-microbial drugs are least likely to develop seizures?",
      "choices": [
        {
          "id": 1,
          "text": "Beta lactam compounds"
        },
        {
          "id": 2,
          "text": "Quinolones"
        },
        {
          "id": 3,
          "text": "Macrolides"
        },
        {
          "id": 4,
          "text": "Isoniazid"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Macrolides</strong> are the <strong>least likely</strong> anti-microbial out of the given options to cause <strong>seizures.</strong></p>\n<p><strong>Antimicrobials associated</strong> with <strong>causing seizures:&nbsp;</strong></p>\n<ul>\n<li>Beta-lactam and related compounds</li>\n<li>Quinolones</li>\n<li>Acyclovir</li>\n<li>Isoniazid</li>\n<li>Ganciclovir</li>\n</ul>\n<p>Other groups of <strong>drugs</strong> that are <strong>implicated</strong> in causing <strong>epilepsy:</strong></p>\n<ul>\n<li>Alkylating agents - busulfan, chlorambucil</li>\n<li>Antimalarials - chloroquine, mefloquine</li>\n<li>Anesthetics/ analgesics - meperidine, fentanyl, tramadol, local anesthetics</li>\n<li>Immunomodulatory drugs - cyclosporine, tacrolimus, interferons</li>\n<li>Psychotropics:\n<ul>\n<li>Antidepressants - bupropion</li>\n<li>Antipsychotics - clozapine</li>\n<li>Anti-manic drugs - lithium</li>\n</ul>\n</li>\n<li>Drugs of abuse - amphetamine, cocaine, phencyclidine, methylphenidate</li>\n<li>Miscellaneous - Theophylline, memantine.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1580",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following drugs of abuse is least likely to be associated with seizures?",
      "choices": [
        {
          "id": 1,
          "text": "Amphetamine"
        },
        {
          "id": 2,
          "text": "Cocaine"
        },
        {
          "id": 3,
          "text": "Cannabinoids"
        },
        {
          "id": 4,
          "text": "Phencyclidine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cannabinoids </strong>are being investigated for the <strong>treatment</strong> of various types of <strong>epilepsy</strong> and are <strong>least likely</strong> to <strong>cause</strong> seizures.</p>\n<p>Drugs of <strong>abuse</strong> that are <strong>implicated</strong> in causing <strong>seizures</strong> are:&nbsp;</p>\n<ul>\n<li>Amphetamine</li>\n<li>Cocaine</li>\n<li>Phencyclidine</li>\n<li>Methylphenidate</li>\n</ul><p>The FDA recently approved cannabidiol oral solution for the treatment of seizures associated with tuberous sclerosis complex in patients one year of age and older. It was previously approved for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1581",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented to the OPD with a skin rash for 3 days. He gives a history of antiepileptic drug use for 2 months and is ataxic on examination. He is diagnosed to have Stevens-Johnson syndrome. Which of the following drugs are implicated in these adverse effects?",
      "choices": [
        {
          "id": 1,
          "text": "Phenobarbital"
        },
        {
          "id": 2,
          "text": "Lamotrigine"
        },
        {
          "id": 3,
          "text": "Topiramate"
        },
        {
          "id": 4,
          "text": "Ethosuximide"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Lamotrigine</strong> is known to cause such adverse effects in patients.</p>\n<p>Adverse effects of lamotrigine:</p>\n<ul>\n<li>Skin rash</li>\n<li>Stevens-Johnson syndrome</li>\n<li>Dizziness</li>\n<li>Diplopia</li>\n<li>Sedation</li>\n<li>Ataxia</li>\n<li>Headache</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0944",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs if used can lead to behavioral effects such as aggression?",
      "choices": [
        {
          "id": 1,
          "text": "Phenytoin"
        },
        {
          "id": 2,
          "text": "Phenobarbitone"
        },
        {
          "id": 3,
          "text": "Levetiracetam"
        },
        {
          "id": 4,
          "text": "Pregabalin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Children </strong>who are on<strong> levetiracetam </strong>have a <strong>higher risk </strong>of developing several behavioral side-effects such as<strong> aggression</strong>, hostility, and nervousness compared to children who do not use levetiracetam.</p>\n<p>These side effects are seen in less frequency with <strong>brivaracetam</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1576",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drug is approved for use in fibromyalgia?",
      "choices": [
        {
          "id": 1,
          "text": "Gabapentin"
        },
        {
          "id": 2,
          "text": "Pregabalin"
        },
        {
          "id": 3,
          "text": "Tiagabine"
        },
        {
          "id": 4,
          "text": "Topiramate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Pregabalin</strong> is approved for use in <strong>fibromyalgia</strong>. It is also approved for use in diabetic peripheral neuropathy.</p>\n<p>Mechanism of analgesic action:</p>\n<ul>\n<li>Interacts at the binding site of the alpha, delta subunit&nbsp;of voltage-dependent Ca2+ channels</li>\n<li>Correlates with decreased Ca2+ channel function&nbsp;and release of neurotransmitters</li>\n<li>Decreased neurotransmitter release is associated&nbsp;with reduced neuronal hyperexcitability.</li>\n</ul>\n<p>Options A and C: Gabapentin and tiagabine are also useful in fibromyalgia but are not approved for this indication and are used off-label.</p>\n<p>Option D: Topiramate's efficacy is not encouraging in fibromyalgia and neuropathic pain.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2263",
      "difficulty": "medium"
    },
    {
      "text": "What is the first-line treatment for infantile spasms associated with tuberous sclerosis?",
      "choices": [
        {
          "id": 1,
          "text": "ACTH"
        },
        {
          "id": 2,
          "text": "Vigabatrin"
        },
        {
          "id": 3,
          "text": "Glucocorticoids"
        },
        {
          "id": 4,
          "text": "Sodium valproate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Vigabatrin </strong>is particularly effective in <strong>infantile spasms</strong> associated with <strong>tuberous sclerosis</strong> and is considered the first-line treatment in this condition.</p>\n<p><strong>ACTH</strong> is considered to be the drug of choice for <strong>infantile spasms</strong> that are <strong>not associated</strong> with <strong>tuberous sclerosis.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1577",
      "difficulty": "easy"
    }
  ]
}